TIGIT and neoplasm: The anti-MSLN CAR-T cells showed signs of tumor recurrence in the late stage of the experiment, while the MT CAR-T cells and anti-MSLN CAR-T ± anti-α-TIGIT mice showed no tumor recurrence.